Frontlight ResearchEarly access
Trial site
Isehara
- 6running trials
- 2closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Myelodysplastic syndromes3 trials
- Chronic myeloid leukaemia2 trials
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Metastatic breast cancer1 trial
- Multiple sclerosis1 trial
- Myeloproliferative neoplasms1 trial
- Thalassaemia1 trial
- Phase
- Phase 23 trials
- Phase 33 trials
- Phase 41 trial
- Status
- Active, not recruiting6 trials
- Terminated2 trials
- Lead sponsor
- Novartis Pharmaceuticals8 trials
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria
Active, not recruiting
Active, not recruiting
Active, not recruiting
Closed trials
Terminated
Terminated
Site data: ClinicalTrials.govUpdated 12 Nov 2026